TYK Medicines, Inc (HKG:2410)
Hong Kong · Delayed Price · Currency is HKD 14.30
+0.62 (4.53%)
At close: Jan 9, 2026
TYK Medicines Market Cap
TYK Medicines has a market cap or net worth of 5.43 billion as of January 9, 2026. Its market cap has decreased by -64.94% in one year.
Market Cap
5.43B
Enterprise Value
5.19B
Revenue
117.25K
Ranking
n/a
PE Ratio
n/a
Stock Price
14.30
Market Cap Chart
Since August 20, 2024, TYK Medicines's market cap has increased from 5.08B to 5.43B, an increase of 6.98%. That is a compound annual growth rate of 4.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 5.43B | 9.08% |
| Dec 31, 2025 | 4.98B | -71.50% |
| Dec 31, 2024 | 17.48B | 244.16% |
| Aug 20, 2024 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.47B |
| Hansoh Pharmaceutical Group Company | 251.84B |
| JD Health International | 204.91B |
| Innovent Biologics | 153.67B |
| WuXi Biologics | 152.99B |
| Sino Biopharmaceutical | 122.10B |
| Akeso | 117.54B |
| Sichuan Kelun-Biotech Biopharmaceutical | 111.09B |